Many comparative-effectiveness studies do not address fundamental issues, such as how a medicine can be used more effectively, according to a report in the Journal of the American Medical Association. The data "suggest government and noncommercial support should be increased for studies involving nonpharmacologic therapies, for studies comparing different therapeutic strategies, and for studies focusing on the comparative safety and cost of different therapies," researchers said.

Full Story:

Related Summaries